Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 304-21: Transforming the Mental Health Care System with Cultural Safety Care

    Contains 5 Component(s), Includes Credits

    Presenter: Eugenia I. Flores Millender, PhD, RN, PMHNP-BC, CDE 1.5 pharmacology contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    304-21:  Transforming the Mental Health Care System with Cultural Safety Care

    Learn important considerations for providing culturally appropriate care and prescribing psychopharmacological medications for culturally diverse patients.


    Presenter:
      Eugenia I. Flores Millender, PhD, RN, PMHNP-BC, CDE

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.


    Session Length:
      1 hour 34 minutes

    Target Audience:  APRN, RN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Incorporate cuturally sensitive techniques when prescribing to diverse populations.

    Keywords:  Diverse Populations, Equity, Prescribing


    Nursing Continuing Professional Development:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

  • 203-21: Assessment and Treatment of Chronic Pediatric Irritability

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Ellen Leibenluft, MD 1.5 pharmacology contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    203-21:  Assessment and Treatment of Chronic Pediatric Irritability

    Focus in on the assessment and treatment, both psychopharmacologic and psychotherapeutic, of chronic pediatric irritability, which is characterized by developmentally inappropriate temper outbursts and grouchy, angry mood between outbursts.


    Presenter:  Ellen Leibenluft, MD

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will be discussed during this presentation.


    Session Length:
      1 hour 22 minutes

    Target Audience:  APRN, RN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Discuss outcomes of pediatric irritability that have been identified in longitudinal studies.

    Keywords:  Irritability, Child and Adolescent


    Nursing Continuing Professional Development:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

  • 403-21: Psychiatric Treament for Persons with HIV

    Contains 5 Component(s), Includes Credits

    Presenter: Glenn J. Treisman, MD, PhD 1.5 pharmacology contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    403-21:  Psychiatric Treament for Persons with HIV

    Discover the latest best practices in psychopharmacological clinical care for persons infected with HIV as well as insight into the psychiatric aspects of HIV infections.


    Presenter:
      Glenn J. Treisman, MD, PhD

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will be discussed during this presentation.


    Session Length:
      1 hour 20 minutes

    Target Audience:  APRN, RN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Describe the comorbidity between HIV and mental illness and improve treatment of co-morbid mental illiness in practice.

    Keywords:  HIV, Depression


    Nursing Continuing Professional Development:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

  • 404-21: Zooming to the Pharmacy...Pearls and Pitfalls of Teleprescribing Across the Lifespan 

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Joan Burns, DNP, APRN, PMHNP-BC 1.0 pharmacology contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    404-21:  Zooming to the Pharmacy...Pearls and Pitfalls of Teleprescribing Across the Lifespan

    Understand population-specific prescribing guidelines for using telepsychiatry when working with adults or children.


    Presenter:
      Joan Burns, DNP, APRN, PMHNP-BC

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.


    Session Length:
      59 minutes

    Target Audience:  APRN, RN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Apply best practices for the utilization of telepsychiatry for the purpose of teleprescribing.

    Keywords:  Telehealth, Teleprescribing


    Nursing Continuing Professional Development:
    1.0 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

  • 101-21: KEYNOTE:  Mental Health Impacts of COVID-19

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Joshua A. Gordon, MD, PhD 1.25 contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    101-21:  KEYNOTE:  Mental Health Impacts of COVID-19

    Dr. Gordon will review new scientific discoveries and how they impact your practice, with specific attention to emerging research around the current pandemic and mental health.


    Presenter:
      Joshua A. Gordon, MD, PhD

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.


    Session Length:
      1 hour 9 minutes

    Target Audience:  APRN, RN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    • Identify the mental health effects of COVID-19, and the disparities in the prevalence and outcomes of mental illnesses.

    Keywords:  COVID-19, Pandemic, Mental Health, Health Disparities


    Nursing Continuing Professional Development:
    1.25 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

  • 102-21: When Substance Use Impacts the Professional: Recognition, Recovery, and Practice Challenges

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenters: Michelle Knapp, DNP, PMHNP-BC, FIAAN; Robert J. Abel DNP, PMHNP-BC; Maureen Farrell, MSN, RN 1.5 pharmacology contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    102-21:  When Substance Use Impacts the Professional: Recognition, Recovery, and Practice Challenges

    Discuss how individual institution and state regulatory policies surrounding nurses’ treatment for substance use disorders perpetuate stigma and how to shift nursing to a recovery-focused culture.


    Presenters:
      Michelle Knapp, DNP, PMHNP-BC, FIAAN; Robert J. Abel DNP, PMHNP-BC; Maureen Farrell, MSN, RN

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.


    Session Length:
      1 hour 26 minutes

    Target Audience:  APRN, RN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Describe how substance use disorders uniquely impacts nurses and the stigma associated with nurses who use or have used substances.

    Keywords:  Substance Use, Recovery, Recovery Programs


    Nursing Continuing Professional Development:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

  • 201-21: KEYNOTE:  Alcohol Use Disorder: Hyperkatifeia, Deaths of Despair and COVID-19

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: George F. Koob, PhD 1.5 contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    201-21:  KEYNOTE:  Alcohol Use Disorder: Hyperkatifeia, Deaths of Despair and COVID-19

    Delve into the science behind alcohol and stress, especially within the context of the COVID-19 pandemic, as well as current treatments for alcohol use disorder (AUD), such as effective behavioral treatments and FDA approved medications for alcohol misuse.


    Presenter:
      George F. Koob, PhD

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.


    Session Length:
      1 hour 20 minutes

    Target Audience:  APRN, RN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Discuss how alcohol misuse alters the brain, and the impact of the COVID-19 pandemic on alcohol use and treatment.

    Keywords:  Alcohol Use Disorder, Alcohol Misuse, COVID-19


    Nursing Continuing Professional Development:
    1.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

  • 202-21: Integrated Care of Elders to Manage Psychological Stress in the Midst of a Crisis

    Contains 5 Component(s), Includes Credits

    Presenter: Kathleen D. Wright, PhD, RN, APRN-CNS, PMHCNS-BC 1.5 contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    202-21: Integrated Care of Elders to Manage Psychological Stress in the Midst of a Crisis

    Explore chronic stress in aging, including discrimination stress and COVID-19 stress, the physiologic impact, and an integrated approach to stress-management in elders.


    Presenter:
      Kathleen D. Wright, PhD, RN, APRN-CNS, PMHCNS-BC

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.


    Session Length:
      1 hour 27 minutes

    Target Audience:  APRN, RN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Identify strategies to recognize, assess, and treat chronic stress in older adults with comorbid hypertension.

    Keywords:  Chronic Stress, Older Adults, COVID-19, Stress Management


    Nursing Continuing Professional Development:
    1.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

  • 204-21: Gut-Brain Axis and Neuroendocrinology: Translation to Addiction Medicine

    Contains 5 Component(s), Includes Credits

    Presenter: Lorenzo Leggio, MD, PhD 1.5 pharmacology contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    204-21:  Gut-Brain Axis and Neuroendocrinology: Translation to Addiction Medicine

    Better understand systems related to the gut-brain axis and neuroendocrine pathways and develop treatments for alcohol and substance use disorder based on recent preclinical and clinical findings.


    Presenter:
      Lorenzo Leggio, MD, PhD

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will be discussed during this presentation.


    Session Length:
      1 hour 15 minutes

    Target Audience:  APRN, RN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Discuss alcohol use disorder (AUD), treatments for AUD and potential role of gut-brain pathways in AUD.

    Keywords:  Alcohol Use Disorder, Gut-Brain Axis, Neuroendocrinology


    Nursing Continuing Professional Development:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.

  • 301-21: KEYNOTE:  Psychosis: Early Treatment, Outcomes, and Course

    Contains 5 Component(s), Includes Credits

    Presenter: Nina R. Schooler, PhD 1.5 pharmacology contact hours

    For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

    301-21:  KEYNOTE:  Psychosis: Early Treatment, Outcomes, and Course

    Explore the long-term course of treatment for schizophrenia, drawing on data from studies of the first episode of psychosis that include both psychological and pharmacological treatments, recent antipsychotic treatment advances and team-based communication with patients and families.


    Presenter:
      Nina R. Schooler, PhD

    Disclosures:  The presenter has indicated a significant financial interest or other affiliation with Otsuka and Lundbeck.  Off-label use of medications will be discussed during this presentation.The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 20 minutes

    Target Audience:  APRN, RN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Discuss the RAISE-ETP study and PRELAPSE study, and the role of measurement-based care in the treatment of psychosis.

    Keywords:  LAI, Psychosis, Schizophrenia


    Nursing Continuing Professional Development:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


    The contact hours for this session expire:  June 30, 2023


    *Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.